Pay in 4 interest-free payments of $5.91 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
For the first time, the company delivered a positive adjusted EBITDA quarter with the third quarter landing at $2 million compared with a $5 million loss at the third quarter a year ago, Duffy told investors
Saxenda is approved for adolescents aged 12 and older with obesity, making it the only GLP-1 option besides semaglutide with formal pediatric data
Vision : To be the world's leading Contract Development Manufacture Organization (CDMO) enterprise and international trade platform for the pharmaceutical industry
So snh vi cc thuc ung gim cn khc Cc cht ng vn th th GLP-1 (GLP-1RA), nh semaglutide v tirzepatide, cho thy hiu qu vt tri trong iu tr bo ph so vi cc thuc gim cn khc
US$ 27.14
US$ 26.35
US$ 24.80
US$ 20.23
US$ 25.78
US$ 24.22
US$ 24.85
